GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $57.63 $79.59 Wednesday, 17th Apr 2024 EXAS stock ended at $63.22. This is 1.00% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 6.10% from a day low at $62.91 to a day high of $66.74.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
2021-07-06 $122.49 $122.99 $119.56 $122.00 1 426 008
2021-07-02 $124.14 $125.00 $121.25 $122.82 914 533
2021-07-01 $123.43 $125.60 $122.31 $124.05 855 413
2021-06-30 $126.99 $127.43 $123.86 $124.31 1 148 049
2021-06-29 $130.83 $131.99 $127.42 $128.14 806 526
2021-06-28 $131.38 $133.99 $130.07 $131.01 1 141 986
2021-06-25 $129.68 $130.96 $126.42 $128.57 2 045 033
2021-06-24 $131.48 $132.65 $128.00 $128.49 1 428 388
2021-06-23 $127.91 $131.66 $127.50 $130.97 1 188 372
2021-06-22 $128.12 $129.77 $127.11 $127.94 982 603
2021-06-21 $126.40 $128.18 $122.60 $127.66 1 250 709
2021-06-18 $126.41 $127.00 $122.70 $126.52 1 453 659
2021-06-17 $119.83 $127.93 $119.79 $126.90 1 514 087
2021-06-16 $122.78 $123.32 $116.72 $120.38 1 567 904
2021-06-15 $125.55 $125.70 $120.25 $122.57 1 076 873
2021-06-14 $122.95 $125.96 $121.00 $125.01 1 160 524
2021-06-11 $121.71 $124.49 $119.88 $121.89 1 597 531
2021-06-10 $118.89 $122.19 $117.51 $121.91 1 262 261
2021-06-09 $115.56 $120.00 $114.77 $119.20 2 022 651
2021-06-08 $113.97 $116.14 $111.68 $114.03 1 564 715
2021-06-07 $107.54 $112.79 $106.75 $112.06 1 266 389
2021-06-04 $108.60 $109.81 $106.64 $106.83 862 072
2021-06-03 $109.76 $110.85 $105.40 $107.91 1 061 713
2021-06-02 $108.11 $109.91 $107.73 $109.12 1 124 845
2021-06-01 $111.16 $112.41 $106.26 $108.37 1 529 153
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT